Private Equity Firm • Multi-Strategy • Asia

Gemseki Investment

AUM

Not publicly reported

Estimated Dry Powder

Not publicly reported

Fund Size (Latest)

Not publicly reported

Estimated Cheque Size

$104K-$1.0M

Stages

Seed
Series B
Early Stage

Fund Details

Year Established

2024

Website

https://www.gemseki-inv.com/

St Luke’s Tower 28F,8-1 Akashi-cho, Chuo-ku, Tokyo, Tokyo, 104-0044, Japan, Asia

HQ Phone

+81 (0)3 6264 0471

About

Gemseki Investment is a Japan-based private equity firm involved in venture capital investments and a wholly owned subsidiary of SHIN NIPPON BIOMEDICAL LABORATORIES (SNBL), a pharmaceutical company engaged in contract & research organization, research & development and medipolis businesses. The firm invests in venture companies engaged in pharmaceutical and medical device research and development in Japan and overseas. Gemseki Investment was established as a result of SNBL’s decision in July 2024 to split Gemseki’s fund management operation from its core business in pharma licensing. In October 2024, Gemseki Investment inherited Gemseki’s fund management business, while Gemseki was absorbed and merged with SNBL.

HQ Map

No mappable locations available.

Locations

St Luke’s Tower 28F,8-1 Akashi-cho, Chuo-ku, Tokyo, Tokyo, 104-0044, Japan, Asia

Tel: +81 (0)3 6264 0471View map